NAFLD Among Patients With Chronic Kidney Disease and the Effect of Kidney Transplantation
Conditions: Non-Alcoholic Fatty Liver Disease; Chronic Kidney Diseases; PreDiabetes; Kidney Transplant Interventions: Diagnostic Test: MR spectroscopy of the liver; Diagnostic Test: Fibroscan of the liver; Device: Continuous glucose monitoring (CGM) for four days.; Diagnostic Test: Oral glucose tolerance test (OGTT); Diagnostic Test: Intra venous glucose infusion (IIGI); Radiation: Dua l Energy X-ray Absorptiometry (DEXA) scan; Biological: Blood samples; Other: Clinical and demographic data Sponsors: Rigshospitalet, Denmark; Steno Diabetes Center; Herlev and Gentofte Hospital; The Novo Nordisk Foundation Center for Basic Metabolic Research Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials